爱尔兰卫生政策制定的快速证据支持系统评估 - 一项协议
Barbara Whelan1,2, Marie Tierney1,2, Nikita N Burke1,2
1Evidence Synthesis Ireland & Cochrane Ireland, University of Galway, Galway, Ireland.
HRB open research
|August 25, 2025
概括
这项研究详细介绍了评估爱尔兰卫生政策制定证据系统的快速证据支持系统 (RESSA) 协议. 这些发现将加强国家证据基础设施,使政策决策更好.
科学领域:
- 卫生政策
- 基于证据的决策
- 卫生系统研究
背景情况:
- 基于证据的政策制定将可靠的证据纳入政策制定中,考虑可行性,公平性和利益相关者的意见.
- 全球证据委员会强调需要强大的国家证据基础设施和证据支持系统的评估.
- 快速证据支持系统评估 (RESSA) 是为了帮助各国审查其证据支持系统而开发的.
研究的目的:
- 概述爱尔兰卫生政策制定快速证据支持系统评估 (RESSA) 的协议.
- 为评估证据支持系统提供透明和可复制的方法.
- 为加强卫生政策的证据支持系统提供信息.
主要方法:
- 一种灵活的混合方法设计,包括网站审查,文档分析和半结构面试.
- 使用READ方法对文件进行系统的数据分析,对采访进行主题分析.
- 来自多个数据源的结果的三角化,以确保可靠的结论.
主要成果:
- 这个部分不适用,因为摘要描述的是一个协议,而不是结果.
- 这个部分不适用,因为摘要描述的是一个协议,而不是结果.
- 这个部分不适用,因为摘要描述的是一个协议,而不是结果.
结论:
- 该研究方案为评估爱尔兰卫生政策制定的证据支持系统提供了详细的框架.
- 这种记录的方法提高了类似评估的透明度和可复制性.
- 该方法和结果可以为卫生以外的其他领域的证据支持系统提供见解.
相关概念视频
Methods Of Healthcare Delivery System
3.5K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.5K
Principles of Disease Surveillance
180
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
180
Drug Control Governance: Regulatory Bodies and Their Impact
241
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
241
Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Methods of Documentation III: PIE
1.5K
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
1.5K


